We reported that treatment with antibodies for SLAYGLR (M5 Ab) [15] and α9β1 integrin [21] delayed the onset of arthritis as well as attenuating its severity, suggesting that the interaction between thrombin-cleaved OPN and α9β1 integrin is important for the development of arthritis in the early phase. This evidence concerns the gene SPP1 and arthritic joint disease.